Diamond Biotechnology Co., Ltd (6815.TWO)

TWD 70.9

(6.3%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 616.09 Million 434.84 Million 395.2 Million 306.38 Million 268.35 Million
Cost of Revenue 326.5 Million 250.52 Million 207.32 Million 177.96 Million 133.58 Million
Gross Profit 289.59 Million 184.31 Million 187.88 Million 128.42 Million 134.76 Million
Operating Expenses 289.59 Million 137.25 Million 139.78 Million 115.03 Million 77.11 Million
Selling, General and Administrative Expenses 194.88 Million 111.31 Million 111.86 Million 112.14 Million 77.34 Million
Research and Development Expenses 29.33 Million 25.93 Million 27.92 Million 2.89 Million 1.12 Million
Other Expenses - -1.08 Million 6.4 Million 944 Thousand -
Cost and Expenses 550.72 Million 387.77 Million 347.11 Million 292.99 Million 210.7 Million
Operating Income 65.37 Million 46.4 Million 54.53 Million 14.39 Million 56.3 Million
Interest Expense 7.51 Million 3.73 Million 2.27 Million 2.47 Million 1.13 Million
Income Tax Expense 11.59 Million 8.43 Million 10.13 Million 2.45 Million 12.36 Million
Earnings before Tax 58.33 Million 41.82 Million 52.05 Million 13.5 Million 56.54 Million
Net Income 46.73 Million 33.38 Million 41.92 Million 11.04 Million 44.18 Million
Earnings Per Share Basic 1.51 1.20 1.51 0.41 1.93
Earnings Per Share Diluted 1.51 1.20 1.51 0.41 1.92
Weighted Average Shares Outstanding 30.88 Million 27.82 Million 27.82 Million 26.92 Million 22.89 Million
Weighted Average Shares Outstanding (Diluted) 30.88 Million 27.83 Million 27.83 Million 26.93 Million 22.97 Million
Gross Margin 0.47 0.42 0.48 0.42 0.50
EBIT Margin 0.19 0.23 0.29 0.23 0.29
Profit Margin 0.08 0.08 0.11 0.04 0.16
EBITDA 116.16 Million 99.88 Million 112.71 Million 69.21 Million 79.07 Million
Earnings Before Tax Margin 0.11 0.11 0.14 0.05 0.21

Income Statement Charts